{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:11:11Z","timestamp":1794553871609,"version":"4.9.1"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02131-1","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T09:04:42Z","timestamp":1772528682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ion channels and GPCRs as pharmacological regulators of ferroptosis and pyroptosis in metabolic diseases"],"prefix":"10.1186","volume":"18","author":[{"given":"Fahrul","family":"Nurkolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2131_CR1","doi-asserted-by":"publisher","unstructured":"Duan J-Y, Lin X, Xu F, Shan S-K, Guo B, Li F-X-Z et al. Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization? Front Cell Dev Biol [Internet]. 2021 [cited 2026 Jan 9];9. Available from: https:\/\/www.frontiersin.org\/journals\/cell-and-developmental-biology\/articles\/https:\/\/doi.org\/10.3389\/fcell.2021.701788\/full","DOI":"10.3389\/fcell.2021.701788\/full"},{"key":"2131_CR2","doi-asserted-by":"publisher","unstructured":"Li X, Xiao G-Y, Guo T, Song Y-J, Li Q-M. Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications. Front Endocrinol [Internet]. 2022 [cited 2026 Jan 9];13. Available from: https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/https:\/\/doi.org\/10.3389\/fendo.2022.986565\/full","DOI":"10.3389\/fendo.2022.986565\/full"},{"key":"2131_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05708-0","volume":"14","author":"R Miao","year":"2023","unstructured":"Miao R, Fang X, Zhang Y, Wei J, Zhang Y, Tian J. Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities. Cell Death Dis. 2023;14:186. https:\/\/doi.org\/10.1038\/s41419-023-05708-0.","journal-title":"Cell Death Dis"},{"key":"2131_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00004.2024","volume":"105","author":"S Incontro","year":"2025","unstructured":"Incontro S, Musella ML, Sammari M, Di Scala C, Fantini J, Debanne D. Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives. Physiol Rev. 2025;105:137\u2013207. https:\/\/doi.org\/10.1152\/physrev.00004.2024.","journal-title":"Physiol Rev"},{"key":"2131_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s11010-022-04602-1","volume":"478","author":"X Xu","year":"2023","unstructured":"Xu X, Wu X, Yue G, An Q, Lou J, Yang X, et al. The role of Nod-like receptor protein 3 inflammasome activated by ion channels in multiple diseases. Mol Cell Biochem. 2023;478:1397\u2013410. https:\/\/doi.org\/10.1007\/s11010-022-04602-1.","journal-title":"Mol Cell Biochem"},{"key":"2131_CR6","doi-asserted-by":"crossref","unstructured":"Wang H, Xie Y, Wang H, Xie Y. Advances in Ferroptosis Research: A Comprehensive Review of Mechanism Exploration, Drug Development, and Disease Treatment. Pharmaceuticals [Internet]. 2025 [cited 2026 Jan 9];18. Available from: https:\/\/www.mdpi.com\/1424-8247\/18\/3\/334","DOI":"10.3390\/ph18030334"},{"key":"2131_CR7","doi-asserted-by":"crossref","unstructured":"Strukel S, Teshome B, Rai V, Strukel S, Teshome B, Rai V. The Multifaceted Role of Platelets in Atherosclerosis and Ischemic Disease: Pathogenesis, Inflammation, and Therapeutic Opportunities. Life [Internet]. 2025 [cited 2026 Jan 9];15. Available from: https:\/\/www.mdpi.com\/2075-1729\/15\/11\/1656.","DOI":"10.3390\/life15111656"},{"key":"2131_CR8","volume-title":"Metabolism and Medicine: The Metabolic Landscape of Health and Disease (Volume 2)","author":"B Fertig","year":"2022","unstructured":"Fertig B. Metabolism and Medicine: The Metabolic Landscape of Health and Disease (Volume 2). Boca Raton: CRC; 2022."},{"key":"2131_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/physiol.00029.2023","volume":"39","author":"Y Hirata","year":"2024","unstructured":"Hirata Y, Mishima E. Membrane dynamics and cation handling in ferroptosis. Physiology (Bethesda). 2024;39:73\u201387. https:\/\/doi.org\/10.1152\/physiol.00029.2023.","journal-title":"Physiology (Bethesda)"},{"key":"2131_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02859-1","volume":"12","author":"W Lu","year":"2026","unstructured":"Lu W, Deng Y, Liu M, Hu Y, Yang K, Wang B, et al. Regulation of apoptosis, ferroptosis, and pyroptosis mediated by acetylation. Cell Death Discov. 2026;12:15. https:\/\/doi.org\/10.1038\/s41420-025-02859-1.","journal-title":"Cell Death Discov"},{"key":"2131_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107579","volume":"212","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ma K, Fang X, Zhang Y, Miao R, Guan H, et al. Targeting ion homeostasis in metabolic diseases: molecular mechanisms and targeted therapies. Pharmacol Res. 2025;212:107579. https:\/\/doi.org\/10.1016\/j.phrs.2025.107579.","journal-title":"Pharmacol Res"},{"key":"2131_CR12","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.devcel.2024.09.004","volume":"59","author":"J Khatun","year":"2024","unstructured":"Khatun J, Gelles JD, Chipuk JE. Dynamic death decisions: how mitochondrial dynamics shape cellular commitment to apoptosis and ferroptosis. Dev Cell. 2024;59:2549\u201365. https:\/\/doi.org\/10.1016\/j.devcel.2024.09.004.","journal-title":"Dev Cell"},{"key":"2131_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1678-y","volume":"10","author":"S Tsurusaki","year":"2019","unstructured":"Tsurusaki S, Tsuchiya Y, Koumura T, Nakasone M, Sakamoto T, Matsuoka M, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 2019;10:449. https:\/\/doi.org\/10.1038\/s41419-019-1678-y.","journal-title":"Cell Death Dis"},{"key":"2131_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3748\/wjg.v29.i4.616","volume":"29","author":"E Kouroumalis","year":"2023","unstructured":"Kouroumalis E, Tsomidis I, Voumvouraki A. Iron as a therapeutic target in chronic liver disease. World J Gastroenterol. 2023;29:616\u201355. https:\/\/doi.org\/10.3748\/wjg.v29.i4.616.","journal-title":"World J Gastroenterol"},{"key":"2131_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123328","volume":"10","author":"EA Vilas-Boas","year":"2021","unstructured":"Vilas-Boas EA, Almeida DC, Roma LP, Ortis F, Carpinelli AR. Lipotoxicity and \u03b2-cell failure in type 2 diabetes: oxidative stress linked to NADPH oxidase and ER stress. Cells. 2021;10:3328. https:\/\/doi.org\/10.3390\/cells10123328.","journal-title":"Cells"},{"key":"2131_CR16","doi-asserted-by":"publisher","first-page":"18115","DOI":"10.2147\/JIR.S567900","volume":"18","author":"K Zou","year":"2025","unstructured":"Zou K, Liu W, Xia W, Zhao Y. Ferroptosis in hypertriglyceridemic acute pancreatitis: mechanisms and therapeutic implications. Journal of Inflammation Research [Internet]. 2025;18:18115\u201335. https:\/\/doi.org\/10.2147\/JIR.S567900.","journal-title":"Journal of Inflammation Research [Internet]"},{"key":"2131_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cmet.2024.11.010","volume":"37","author":"X Wang","year":"2025","unstructured":"Wang X, Wu Q, Zhong M, Chen Y, Wang Y, Li X, et al. Adipocyte-derived ferroptotic signaling mitigates obesity. Cell Metab. 2025;37:673-691.e7. https:\/\/doi.org\/10.1016\/j.cmet.2024.11.010.","journal-title":"Cell Metab"},{"key":"2131_CR18","doi-asserted-by":"publisher","unstructured":"Zhou J, Zhou Z, Liu X, Yin H-Y, Tang Y, Cao X. P2X7 Receptor\u2013Mediated Inflammation in Cardiovascular Disease. Front Pharmacol [Internet]. 2021 [cited 2026 Jan 9];12. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2021.654425\/full","DOI":"10.3389\/fphar.2021.654425\/full"},{"key":"2131_CR19","doi-asserted-by":"crossref","unstructured":"Grigg LM, Shrkihe BA, Efimova I, Solodeev I, Shteingard Y, Shani N et al. NLRP3 Deficiency in Nonimmune Cells Averts Obesity-Induced Fatty Liver Disease. Laboratory Investigation [Internet]. 2024 [cited 2026 Jan 9];104. Available from: https:\/\/www.laboratoryinvestigation.org\/article\/S0023-6837(23)00251-9\/fulltext","DOI":"10.1016\/j.labinv.2023.100308"},{"key":"2131_CR20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/jcp.30627","volume":"237","author":"P Miao","year":"2022","unstructured":"Miao P, Ruiqing T, Yanrong L, Zhuwen S, Huan Y, Qiong W, et al. Pyroptosis: a possible link between obesity-related inflammation and inflammatory diseases. J Cell Physiol. 2022;237:1245\u201365. https:\/\/doi.org\/10.1002\/jcp.30627.","journal-title":"J Cell Physiol"},{"key":"2131_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114690","volume":"156","author":"Z Cai","year":"2025","unstructured":"Cai Z, Sun F, Wang Q, Li S, Wang L, Li H, et al. Icariin alleviates cardiomyocyte pyroptosis through AMPK-NLRP3 pathway to ameliorates diabetic cardiomyopathy. Int Immunopharmacol. 2025;156:114690. https:\/\/doi.org\/10.1016\/j.intimp.2025.114690.","journal-title":"Int Immunopharmacol"},{"key":"2131_CR22","doi-asserted-by":"crossref","unstructured":"Zhang L, Ai C, Bai M, Niu J, Zhang Z, Zhang L et al. NLRP3 Inflammasome\/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy. International Journal of Molecular Sciences [Internet]. 2022 [cited 2026 Jan 9];23. Available from: https:\/\/www.mdpi.com\/1422-0067\/23\/18\/10632","DOI":"10.3390\/ijms231810632"},{"key":"2131_CR23","doi-asserted-by":"publisher","unstructured":"Yu L, Hong W, Lu S, Li Y, Guan Y, Weng X et al. The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment. Front Pharmacol [Internet]. 2022 [cited 2026 Jan 9];13. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2022.780496\/full","DOI":"10.3389\/fphar.2022.780496\/full"},{"key":"2131_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01958-2","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu Y, Pan R, Ouyang Y, Gu W, Xiao T, Yang H, et al. Pyroptosis in health and disease: mechanisms, regulation and clinical perspective. Sig Transduct Target Ther. 2024;9:245. https:\/\/doi.org\/10.1038\/s41392-024-01958-2.","journal-title":"Sig Transduct Target Ther"},{"key":"2131_CR25","doi-asserted-by":"publisher","unstructured":"Wang X, Wang W, Zhang R, Ma B, Ni L, Feng H et al. Melatonin attenuates high glucose\u2013induced endothelial cell pyroptosis by activating the Nrf2 pathway to inhibit NLRP3 inflammasome activation. Molecular Medicine Reports [Internet]. 2023;27:1\u201310. Available from: https:\/\/doi.org\/10.3892\/mmr.2023.12958","DOI":"10.3892\/mmr.2023.12958"},{"key":"2131_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00579-w","volume":"7","author":"Y Yu","year":"2021","unstructured":"Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021;7:193. https:\/\/doi.org\/10.1038\/s41420-021-00579-w.","journal-title":"Cell Death Discov"},{"key":"2131_CR27","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y, et al. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol. 2023;97:1439\u201351. https:\/\/doi.org\/10.1007\/s00204-023-03476-6.","journal-title":"Arch Toxicol"},{"key":"2131_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1089\/ars.2020.8243","volume":"35","author":"S Cuevas","year":"2021","unstructured":"Cuevas S, Pelegr\u00edn P. Pyroptosis and redox balance in kidney diseases. Antioxidants & Redox Signaling. 2021;35:40\u201360. https:\/\/doi.org\/10.1089\/ars.2020.8243.","journal-title":"Antioxidants & Redox Signaling"},{"key":"2131_CR29","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.7150\/ijbs.102424","volume":"20","author":"X Chang","year":"2024","unstructured":"Chang X, Zhou H, Hu J, Ge T, He K, Chen Y, et al. Targeting mitochondria by lipid-selenium conjugate drug results in malate\/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression. Int J Biol Sci. 2024;20:5793\u2013811. https:\/\/doi.org\/10.7150\/ijbs.102424.","journal-title":"Int J Biol Sci"},{"key":"2131_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156982","volume":"145","author":"X Pu","year":"2025","unstructured":"Pu X, Wu Q, Yan Z, Zhou S, Zhang Q, Zhang X, et al. Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury. Phytomedicine. 2025;145:156982. https:\/\/doi.org\/10.1016\/j.phymed.2025.156982.","journal-title":"Phytomedicine"},{"key":"2131_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03420-z","volume":"23","author":"J Wang","year":"2025","unstructured":"Wang J, Zhuang H, Li C, Cai R, Shi H, Pang B, et al. Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance. J Nanobiotechnology. 2025;23:383. https:\/\/doi.org\/10.1186\/s12951-025-03420-z.","journal-title":"J Nanobiotechnology"},{"key":"2131_CR32","doi-asserted-by":"publisher","unstructured":"Kulbacka J, Choroma\u0144ska A, Rossowska J, We\u017cgowiec J, Saczko J, Rols M-P. Cell Membrane Transport Mechanisms: Ion Channels and Electrical Properties of Cell Membranes. In: Kulbacka J, Satkauskas S, editors. Transport Across Natural and Modified Biological Membranes and its Implications in Physiology and Therapy [Internet]. Cham: Springer International Publishing; 2017 [cited 2026 Jan 9]. pp. 39\u201358. Available from: https:\/\/doi.org\/10.1007\/978-3-319-56895-9_3","DOI":"10.1007\/978-3-319-56895-9_3"},{"key":"2131_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ceca.2017.05.007","volume":"70","author":"P Maher","year":"2018","unstructured":"Maher P, van Leyen K, Dey PN, Honrath B, Dolga A, Methner A. The role of Ca2\u2009+\u2009in cell death caused by oxidative glutamate toxicity and ferroptosis. Cell Calcium. 2018;70:47\u201355. https:\/\/doi.org\/10.1016\/j.ceca.2017.05.007.","journal-title":"Cell Calcium"},{"key":"2131_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/27697061.2023.2203235","volume":"43","author":"S Samanta","year":"2024","unstructured":"Samanta S, Chakraborty S, Bagchi D. Pathogenesis of neurodegenerative diseases and the protective role of natural bioactive components. J Am Coll Nutr. 2024;43:20\u201332. https:\/\/doi.org\/10.1080\/27697061.2023.2203235.","journal-title":"J Am Coll Nutr"},{"key":"2131_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5483\/BMBRep.2023-0002","volume":"56","author":"Y-J Kim","year":"2023","unstructured":"Kim Y-J, Hyun J. Mechanosensitive ion channels in apoptosis and ferroptosis: focusing on the role of Piezo1. BMB Rep. 2023;56:145\u201352. https:\/\/doi.org\/10.5483\/BMBRep.2023-0002.","journal-title":"BMB Rep"},{"key":"2131_CR36","doi-asserted-by":"crossref","unstructured":"Piciu F, Balas M, Badea MA, Cucu D, Piciu F, Balas M et al. TRP Channels in Tumoral Processes Mediated by Oxidative Stress and Inflammation. Antioxidants [Internet]. 2023 [cited 2026 Jan 9];12. Available from: https:\/\/www.mdpi.com\/2076-3921\/12\/7\/1327.","DOI":"10.3390\/antiox12071327"},{"key":"2131_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7150\/thno.103384","volume":"15","author":"Q Shi","year":"2025","unstructured":"Shi Q, Yang Z, Yang H, Xu L, Xia J, Gu J, et al. Targeting ion channels: innovative approaches to combat cancer drug resistance. Theranostics. 2025;15:521\u201345. https:\/\/doi.org\/10.7150\/thno.103384.","journal-title":"Theranostics"},{"key":"2131_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2040-4603.2021.tb00189.x","volume":"11","author":"B Thompson","year":"2021","unstructured":"Thompson B, Satin LS. Beta-cell ion channels and their role in regulating insulin secretion. Compr Physiol. 2021;11:1\u201321. https:\/\/doi.org\/10.1002\/j.2040-4603.2021.tb00189.x.","journal-title":"Compr Physiol"},{"key":"2131_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1.","journal-title":"Cell Res"},{"key":"2131_CR40","doi-asserted-by":"publisher","first-page":"8265","DOI":"10.2147\/DDDT.S531109","volume":"19","author":"X Wang","year":"2025","unstructured":"Wang X, Deng T, Zhu H, Peng J, Liang J, Zhong S, et al. Chinese herbal medicine in hypoxic pulmonary hypertension treatment: mechanisms, progress, and future directions. Drug Des Devel Ther. 2025;19:8265\u201394. https:\/\/doi.org\/10.2147\/DDDT.S531109.","journal-title":"Drug Des Devel Ther"},{"key":"2131_CR41","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/med.21934","volume":"43","author":"J-B Zhang","year":"2023","unstructured":"Zhang J-B, Tong J, Sun D-Y, Fu J-T, Li D-J, Wang P. Targeting ferroptosis in cardio-metabolic-diseases: mechanisms and therapeutic prospects. Med Res Rev. 2023;43:683\u2013712. https:\/\/doi.org\/10.1002\/med.21934.","journal-title":"Med Res Rev"},{"key":"2131_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-03001-2","volume":"24","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Wang M, Zhou N, Wang Y. Ferroptosis in the pathogenesis of diabetic cardiomyopathy: mechanisms and therapeutic potential. Cardiovasc Diabetol. 2025;24:449. https:\/\/doi.org\/10.1186\/s12933-025-03001-2.","journal-title":"Cardiovasc Diabetol"},{"key":"2131_CR43","doi-asserted-by":"publisher","unstructured":"Kuang F, Liu J, Tang D, Kang R. Oxidative Damage and Antioxidant Defense in Ferroptosis. Front Cell Dev Biol [Internet]. 2020 [cited 2026 Jan 9];8. Available from: https:\/\/www.frontiersin.org\/journals\/cell-and-developmental-biology\/articles\/https:\/\/doi.org\/10.3389\/fcell.2020.586578\/full","DOI":"10.3389\/fcell.2020.586578\/full"},{"key":"2131_CR44","doi-asserted-by":"crossref","unstructured":"Moon D-ONADPH, Dynamics. Linking Insulin Resistance and \u03b2-Cells Ferroptosis in Diabetes Mellitus. International Journal of Molecular Sciences [Internet]. 2023 [cited 2026 Jan 9];25. Available from: https:\/\/www.mdpi.com\/1422-0067\/25\/1\/342","DOI":"10.3390\/ijms25010342"},{"key":"2131_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9999612","volume":"2021","author":"W Sha","year":"2021","unstructured":"Sha W, Hu F, Xi Y, Chu Y, Bu S. Mechanism of ferroptosis and its role in type 2 diabetes mellitus. J Diabetes Res. 2021;2021:9999612. https:\/\/doi.org\/10.1155\/2021\/9999612.","journal-title":"J Diabetes Res"},{"key":"2131_CR46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2022.05.024","volume":"187","author":"Q Li","year":"2022","unstructured":"Li Q, Liao J, Chen W, Zhang K, Li H, Ma F, et al. NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2\/Gpx4 pathway. Free Radic Biol Med. 2022;187:158\u201370. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.05.024.","journal-title":"Free Radic Biol Med"},{"key":"2131_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Sig Transduct Target Ther [Internet]. 2024;9:271. https:\/\/doi.org\/10.1038\/s41392-024-01969-z.","journal-title":"Sig Transduct Target Ther [Internet]"},{"key":"2131_CR48","doi-asserted-by":"crossref","unstructured":"Chatzikalil E, Arvanitakis K, Kalopitas G, Florentin M, Germanidis G, Koufakis T et al. Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches. Cancers [Internet]. 2025 [cited 2026 Jan 9];17. Available from: https:\/\/www.mdpi.com\/2072-6694\/17\/3\/392.","DOI":"10.3390\/cancers17030392"},{"key":"2131_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1545339","volume":"16","author":"D Sun","year":"2025","unstructured":"Sun D, Wang L, Wu Y, Yu Y, Yao Y, Yang H, et al. Lipid metabolism in ferroptosis: mechanistic insights and therapeutic potential. Front Immunol. 2025;16:1545339. https:\/\/doi.org\/10.3389\/fimmu.2025.1545339.","journal-title":"Front Immunol"},{"key":"2131_CR50","doi-asserted-by":"publisher","unstructured":"Huang D, Dai Z, Wang C, Mai H, Zhao J, Cao L et al. Ferroptosis is determined by chloride ions [Internet]. 2023 [cited 2026 Jan 9]. Available from: https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/2023.02.07.526847v1","DOI":"10.1101\/2023.02.07.526847v1"},{"key":"2131_CR51","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2337\/dbi23-0031","volume":"73","author":"GA Rutter","year":"2024","unstructured":"Rutter GA, Sweet IR. Glucose regulation of \u03b2-cell KATP channels: is a new model needed? Diabetes. 2024;73:849\u201355. https:\/\/doi.org\/10.2337\/dbi23-0031.","journal-title":"Diabetes"},{"key":"2131_CR52","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cub.2023.02.060","volume":"33","author":"Y Hirata","year":"2023","unstructured":"Hirata Y, Cai R, Volchuk A, Steinberg BE, Saito Y, Matsuzawa A, et al. Lipid peroxidation increases membrane tension, Piezo1 gating, and cation permeability to execute ferroptosis. Curr Biol. 2023;33:1282-1294.e5. https:\/\/doi.org\/10.1016\/j.cub.2023.02.060.","journal-title":"Curr Biol"},{"key":"2131_CR53","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pbiomolbio.2025.05.001","volume":"196","author":"Q Li","year":"2025","unstructured":"Li Q, Li C, Liu X, Guo Z, Li X, Zhang X. The key role of Piezo1 channels in ferroptosis after spinal cord injury and the therapeutic potential of Piezo1 inhibitors. Progress in Biophysics and Molecular Biology [Internet]. 2025;196:132\u201340. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2025.05.001.","journal-title":"Progress in Biophysics and Molecular Biology [Internet]"},{"key":"2131_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1146\/annurev-pharmtox-031620-105135","volume":"61","author":"D Bakowski","year":"2021","unstructured":"Bakowski D, Murray F, Parekh AB. Store-operated Ca2\u2009+\u2009channels: mechanism, function, pharmacology, and therapeutic targets. Annu Rev Pharmacol Toxicol. 2021;61:629\u201354. https:\/\/doi.org\/10.1146\/annurev-pharmtox-031620-105135.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2131_CR55","doi-asserted-by":"crossref","unstructured":"Rubaiy HN. ORAI Calcium Channels: Regulation, Function, Pharmacology, and Therapeutic Targets. Pharmaceuticals [Internet]. 2023 [cited 2026 Jan 9];16. Available from: https:\/\/www.mdpi.com\/1424-8247\/16\/2\/162","DOI":"10.3390\/ph16020162"},{"key":"2131_CR56","unstructured":"Wang M, Mo D, Zhang N, Yu H. Ferroptosis in diabetic cardiomyopathy: Advances in cardiac fibroblast-cardiomyocyte interactions. Heliyon [Internet]. 2024 [cited 2026 Jan 9];10. Available from: https:\/\/www.cell.com\/heliyon\/abstract\/S2405-8440(24)11250-9"},{"key":"2131_CR57","doi-asserted-by":"publisher","unstructured":"Tian M, Huang X, Li M, Lou P, Ma H, Jiang X et al. Ferroptosis in diabetic cardiomyopathy: from its mechanisms to therapeutic strategies. Front Endocrinol [Internet]. 2024 [cited 2026 Jan 9];15. Available from: https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/https:\/\/doi.org\/10.3389\/fendo.2024.1421838\/full","DOI":"10.3389\/fendo.2024.1421838\/full"},{"key":"2131_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41581-022-00539-2","volume":"18","author":"NA Hukriede","year":"2022","unstructured":"Hukriede NA, Soranno DE, Sander V, Perreau T, Starr MC, Yuen PST, et al. Experimental models of acute kidney injury for translational research. Nat Rev Nephrol. 2022;18:277\u201393. https:\/\/doi.org\/10.1038\/s41581-022-00539-2.","journal-title":"Nat Rev Nephrol"},{"key":"2131_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.71230","volume":"13","author":"L Yang","year":"2025","unstructured":"Yang L, Jiang Y, Wu H, Sun J, Huang X, Hong J, et al. Metabolic functions and mechanisms of selenium, selenocysteine, and GPX4 mediated immune regulation through autophagy in solid tumors. Food Sci Nutr. 2025;13:e71230. https:\/\/doi.org\/10.1002\/fsn3.71230.","journal-title":"Food Sci Nutr"},{"key":"2131_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/abbs\/gmaa155","volume":"53","author":"C Li","year":"2021","unstructured":"Li C, Chen M, He X, Ouyang D. A mini-review on ion fluxes that regulate NLRP3 inflammasome activation. Acta Biochim Biophys Sin (Shanghai). 2021;53:131\u20139. https:\/\/doi.org\/10.1093\/abbs\/gmaa155.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2131_CR61","doi-asserted-by":"crossref","unstructured":"Ren W, Rubini P, Tang Y, Engel T, Illes P, Ren W et al. Inherent P2X7 Receptors Regulate Macrophage Functions during Inflammatory Diseases. International Journal of Molecular Sciences [Internet]. 2021 [cited 2026 Jan 9];23. Available from: https:\/\/www.mdpi.com\/1422-0067\/23\/1\/232","DOI":"10.3390\/ijms23010232"},{"key":"2131_CR62","doi-asserted-by":"crossref","unstructured":"Rossato M, Vincenzo AD, Pagano C, Hadi HE, Vettor R, Rossato M et al. The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review. Cells [Internet]. 2020 [cited 2026 Jan 9];9. Available from: https:\/\/www.mdpi.com\/2073-4409\/9\/4\/1047.","DOI":"10.3390\/cells9041047"},{"key":"2131_CR63","doi-asserted-by":"publisher","first-page":"414","DOI":"10.20959\/wjpr202418-33937","volume":"13","author":"B Singh","year":"2024","unstructured":"Singh B, Kajla V, Bala N, Jassal R, Sayam M, Kalyan S. INVESTIGATING THERAPEUTIC POTENTIAL: P2X7 RECEPTOR ANTAGONISTS IN COMBATING CHRONIC COMPLICATIONS *Corresponding Author. World Journal of Pharmaceutical Research. 2024;13:414\u201335. https:\/\/doi.org\/10.20959\/wjpr202418-33937.","journal-title":"World Journal of Pharmaceutical Research"},{"key":"2131_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04786-w","volume":"13","author":"H Kong","year":"2022","unstructured":"Kong H, Zhao H, Chen T, Song Y, Cui Y. Targeted P2X7\/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy. Cell Death Dis. 2022;13:336. https:\/\/doi.org\/10.1038\/s41419-022-04786-w.","journal-title":"Cell Death Dis"},{"key":"2131_CR65","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000515740","volume":"13","author":"RS Gabarin","year":"2021","unstructured":"Gabarin RS, Li M, Zimmel PA, Marshall JC, Li Y, Zhang H. Intracellular and extracellular lipopolysaccharide signaling in sepsis: avenues for novel therapeutic strategies. J Innate Immun. 2021;13:323\u201332. https:\/\/doi.org\/10.1159\/000515740.","journal-title":"J Innate Immun"},{"key":"2131_CR66","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.1007\/s12035-019-1638-7","volume":"56","author":"JKY Yap","year":"2019","unstructured":"Yap JKY, Pickard BS, Chan EWL, Gan SY. The role of neuronal NLRP1 inflammasome in Alzheimer\u2019s disease: bringing neurons into the neuroinflammation game. Mol Neurobiol. 2019;56:7741\u201353. https:\/\/doi.org\/10.1007\/s12035-019-1638-7.","journal-title":"Mol Neurobiol"},{"key":"2131_CR67","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41573-021-00154-z","volume":"20","author":"X Liu","year":"2021","unstructured":"Liu X, Xia S, Zhang Z, Wu H, Lieberman J. Channelling inflammation: gasdermins in physiology and disease. Nat Rev Drug Discov. 2021;20:384\u2013405. https:\/\/doi.org\/10.1038\/s41573-021-00154-z.","journal-title":"Nat Rev Drug Discov"},{"key":"2131_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2024.106650","volume":"175","author":"Q Wu","year":"2024","unstructured":"Wu Q, Wang Y, Liu J, Guan X, Chang X, Liu Z, et al. Microtubules and cardiovascular diseases: insights into pathology and therapeutic strategies. Int J Biochem Cell Biol. 2024;175:106650. https:\/\/doi.org\/10.1016\/j.biocel.2024.106650.","journal-title":"Int J Biochem Cell Biol"},{"key":"2131_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101034","volume":"14","author":"K Yang","year":"2024","unstructured":"Yang K, Zhang P, Li J, Zhang G, Chang X. Potential of natural drug modulation of endoplasmic reticulum stress in the treatment of myocardial injury. J Pharm Anal. 2024;14:101034. https:\/\/doi.org\/10.1016\/j.jpha.2024.101034.","journal-title":"J Pharm Anal"},{"key":"2131_CR70","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jgr.2025.04.006","volume":"49","author":"X Pu","year":"2025","unstructured":"Pu X, Liu J, Wang Y, Guan X, Wu Q, Zhang Q, et al. Ginsenoside Rb1 attenuates coronary microvascular inflammatory injury via NDUFS4-SIRT5-DUSP1-mediated mitochondrial quality control in a murine ischemia-reperfusion model. J Ginseng Res. 2025;49:509\u201322. https:\/\/doi.org\/10.1016\/j.jgr.2025.04.006.","journal-title":"J Ginseng Res"},{"key":"2131_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106013","volume":"136","author":"SR Mishra","year":"2021","unstructured":"Mishra SR, Mahapatra KK, Behera BP, Patra S, Bhol CS, Panigrahi DP, et al. Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics. Int J Biochem Cell Biol. 2021;136:106013. https:\/\/doi.org\/10.1016\/j.biocel.2021.106013.","journal-title":"Int J Biochem Cell Biol"},{"key":"2131_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108719","volume":"108","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Huang Y, Chen M, Yang Y, Li X, Zhang W. Mitochondrial DNA in NLRP3 inflammasome activation. Int Immunopharmacol. 2022;108:108719. https:\/\/doi.org\/10.1016\/j.intimp.2022.108719.","journal-title":"Int Immunopharmacol"},{"key":"2131_CR73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s12276-022-00729-9","volume":"54","author":"W Zhang","year":"2022","unstructured":"Zhang W, Li G, Luo R, Lei J, Song Y, Wang B, et al. Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis. Exp Mol Med. 2022;54:129\u201342. https:\/\/doi.org\/10.1038\/s12276-022-00729-9.","journal-title":"Exp Mol Med"},{"key":"2131_CR74","unstructured":"Theodorou MP. Factors and mechanisms associating the mobilisation of Ca2\u2009+\u2009with the activation of the NLRP3 inflammasome: A systematic review [Internet]. 2022 [cited 2026 Jan 9]. Available from: https:\/\/urn.kb.se\/resolve?urn=urn:nbn:se:his:diva-21508"},{"key":"2131_CR75","unstructured":"Yousuf A. The relationship between trimethylamine N-oxide and cardiovascular disease: effects on vascular cell function and association with atherosclerotic plaque characteristics [Internet] [thesis]. University of Leicester; 2024 [cited 2026 Jan 9]. Available from: https:\/\/figshare.le.ac.uk\/articles\/thesis\/The_relationship_between_trimethylamine_N-oxide_and_cardiovascular_disease_effects_on_vascular_cell_function_and_association_with_atherosclerotic_plaque_characteristics_\/25053353\/1"},{"key":"2131_CR76","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1348-0421.12771","volume":"64","author":"K Tsuchiya","year":"2020","unstructured":"Tsuchiya K. Inflammasome-associated cell death: pyroptosis, apoptosis, and physiological implications. Microbiol Immunol. 2020;64:252\u201369. https:\/\/doi.org\/10.1111\/1348-0421.12771.","journal-title":"Microbiol Immunol"},{"key":"2131_CR77","doi-asserted-by":"crossref","unstructured":"Tsuchiya K. Switching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity. International Journal of Molecular Sciences [Internet]. 2021 [cited 2026 Jan 9];22. Available from: https:\/\/www.mdpi.com\/1422-0067\/22\/1\/426","DOI":"10.3390\/ijms22010426"},{"key":"2131_CR78","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Rodr\u00edguez C, Mujica P, Illanes-Gonz\u00e1lez J, L\u00f3pez A, Vargas C, S\u00e1ez JC et al. Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation. Biomedicines [Internet]. 2023 [cited 2026 Jan 9];11. Available from: https:\/\/www.mdpi.com\/2227-9059\/11\/6\/1516","DOI":"10.3390\/biomedicines11061516"},{"key":"2131_CR79","doi-asserted-by":"publisher","unstructured":"Zinovkin RA, Lyamzaev KG, Chernyak BV. Current perspectives of mitochondria-targeted antioxidants in cancer prevention and treatment. Front Cell Dev Biol [Internet]. 2023 [cited 2026 Jan 9];11. Available from: https:\/\/www.frontiersin.org\/journals\/cell-and-developmental-biology\/articles\/https:\/\/doi.org\/10.3389\/fcell.2023.1048177\/full","DOI":"10.3389\/fcell.2023.1048177\/full"},{"key":"2131_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107420","volume":"93","author":"Q Gui","year":"2021","unstructured":"Gui Q, Jiang Z, Zhang L. Insights into the modulatory role of cyclosporine A and its research advances in acute inflammation. Int Immunopharmacol. 2021;93:107420. https:\/\/doi.org\/10.1016\/j.intimp.2021.107420.","journal-title":"Int Immunopharmacol"},{"key":"2131_CR81","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","volume":"117","author":"J Zielonka","year":"2017","unstructured":"Zielonka J, Joseph J, Sikora A, Hardy M, Ouari O, Vasquez-Vivar J, et al. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem Rev. 2017;117:10043\u2013120. https:\/\/doi.org\/10.1021\/acs.chemrev.7b00042.","journal-title":"Chem Rev"},{"key":"2131_CR82","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1039\/D5MD00167F","volume":"16","author":"D Deepak Singh","year":"2025","unstructured":"Deepak Singh D. NLRP3 inflammasome: structure, mechanism, drug-induced organ toxicity, therapeutic strategies, and future perspectives. RSC Medicinal Chemistry. 2025;16:2937\u201357. https:\/\/doi.org\/10.1039\/D5MD00167F.","journal-title":"RSC Medicinal Chemistry"},{"key":"2131_CR83","doi-asserted-by":"crossref","unstructured":"Mitsis A, Kyriakou M, Sokratous S, Karmioti G, Drakomathioulakis M, Myrianthefs M et al. Exploring the Landscape of Anti-Inflammatory Trials: A Comprehensive Review of Strategies for Targeting Inflammation in Acute Myocardial Infraction. Biomedicines [Internet]. 2024 [cited 2026 Jan 9];12. Available from: https:\/\/www.mdpi.com\/2227-9059\/12\/3\/701","DOI":"10.3390\/biomedicines12030701"},{"key":"2131_CR84","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1093\/eurheartj\/ehz586","volume":"41","author":"LM Biasucci","year":"2020","unstructured":"Biasucci LM, Pedicino D, Liuzzo G. Promises and challenges of targeting inflammation to treat cardiovascular disease: the post-CANTOS era. Eur Heart J. 2020;41:2164\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehz586.","journal-title":"Eur Heart J"},{"key":"2131_CR85","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8425640","volume":"2022","author":"MM Rahman","year":"2022","unstructured":"Rahman MM, Islam MR, Mim SA, Sultana N, Chellappan DK, Dua K, et al. Insights into the promising prospect of G protein and GPCR-mediated signaling in neuropathophysiology and its therapeutic regulation. Oxid Med Cell Longev. 2022;2022:8425640. https:\/\/doi.org\/10.1155\/2022\/8425640.","journal-title":"Oxid Med Cell Longev"},{"key":"2131_CR86","doi-asserted-by":"crossref","unstructured":"Kaur G, Verma SK, Singh D, Singh NK, Kaur G, Verma SK et al. Role of G-Proteins and GPCRs in Cardiovascular Pathologies. Bioengineering [Internet]. 2023 [cited 2026 Jan 9];10. Available from: https:\/\/www.mdpi.com\/2306-5354\/10\/1\/76","DOI":"10.3390\/bioengineering10010076"},{"key":"2131_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103468","volume":"79","author":"C Lu","year":"2025","unstructured":"Lu C, Xu C, Li S, Ni H, Yang J. Liraglutide and GLP-1(9\u201337) alleviated hepatic ischemia-reperfusion injury by inhibiting ferroptosis via GSK3\u03b2\/Nrf2 pathway and SMAD159\/Hepcidin\/FTH pathway. Redox Biol. 2025;79:103468. https:\/\/doi.org\/10.1016\/j.redox.2024.103468.","journal-title":"Redox Biol"},{"key":"2131_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2025.171429","volume":"192","author":"X Chen","year":"2025","unstructured":"Chen X, Wang T, Gao Y, Wang GA, Guan J, Dai H. Liraglutide suppresses ferroptosis by upregulation NRF2 in type 2 diabetic cardiomyopathy. Peptides. 2025;192:171429. https:\/\/doi.org\/10.1016\/j.peptides.2025.171429.","journal-title":"Peptides"},{"key":"2131_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409781","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Zhou S, Wu W, Lin Y, Wang T, Sun H, et al. GLP-1 receptor agonists alleviate diabetic kidney injury via \u03b2-Klotho-mediated ferroptosis inhibition. Adv Sci. 2025;12:2409781. https:\/\/doi.org\/10.1002\/advs.202409781.","journal-title":"Adv Sci"},{"key":"2131_CR90","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5483\/BMBRep.2024-0067","volume":"57","author":"J Ko","year":"2024","unstructured":"Ko J, Jang S, Jang S, Park S, Yi J, Choi DK, et al. Glucose-dependent insulinotropic polypeptide (GIP) alleviates ferroptosis in aging-induced brain damage through the Epac\/Rap1 signaling pathway. BMB Rep. 2024;57:417\u201323. https:\/\/doi.org\/10.5483\/BMBRep.2024-0067.","journal-title":"BMB Rep"},{"key":"2131_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70392","volume":"39","author":"J Wang","year":"2025","unstructured":"Wang J, Chen H, Wang X. Tirzepatide induces ferroptosis in glioblastoma cell lines via the SOX2\/SLC7A11 axis: a potential therapeutic strategy for glioma treatment. J Biochem Mol Toxicol. 2025;39:e70392. https:\/\/doi.org\/10.1002\/jbt.70392.","journal-title":"J Biochem Mol Toxicol"},{"key":"2131_CR92","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physrev.00041.2018","volume":"100","author":"I Kimura","year":"2020","unstructured":"Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M. Free fatty acid receptors in health and disease. Physiol Rev. 2020;100:171\u2013210. https:\/\/doi.org\/10.1152\/physrev.00041.2018.","journal-title":"Physiol Rev"},{"key":"2131_CR93","doi-asserted-by":"crossref","unstructured":"Grundmann M, Bender E, Schamberger J, Eitner F, Grundmann M, Bender E et al. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators. International Journal of Molecular Sciences [Internet]. 2021 [cited 2026 Jan 9];22. Available from: https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1763","DOI":"10.3390\/ijms22041763"},{"key":"2131_CR94","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.14336\/AD.2023.0216","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu H, Zhang Z. Recent advance in regulatory effect of GRP120 on bone metabolism. Aging Dis. 2023;14:1714\u201327. https:\/\/doi.org\/10.14336\/AD.2023.0216.","journal-title":"Aging Dis"},{"key":"2131_CR95","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2174\/1573401316999201029210912","volume":"17","author":"D Singh","year":"2021","unstructured":"Singh D, Gupta S. Butyrate: a review on beneficial pharmacological and therapeutic effect. Current Nutrition & Food Science. 2021;17:470\u201382. https:\/\/doi.org\/10.2174\/1573401316999201029210912.","journal-title":"Current Nutrition & Food Science"},{"key":"2131_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02305","volume":"9","author":"N Song","year":"2018","unstructured":"Song N, Li T. Regulation of NLRP3 inflammasome by phosphorylation. Front Immunol. 2018;9:2305. https:\/\/doi.org\/10.3389\/fimmu.2018.02305.","journal-title":"Front Immunol"},{"key":"2131_CR97","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.4049\/jimmunol.1401343","volume":"194","author":"M Sokolowska","year":"2015","unstructured":"Sokolowska M, Chen L-Y, Liu Y, Martinez-Anton A, Qi H-Y, Logun C, et al. Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages. J Immunol. 2015;194:5472\u201387. https:\/\/doi.org\/10.4049\/jimmunol.1401343.","journal-title":"J Immunol"},{"key":"2131_CR98","unstructured":"Gibbs W. The Role of the 5-hydroxytrptamine 1F Receptor in Mitochondrial Biogenesis and Acute Kidney Injury. MUSC Theses and Dissertations [Internet]. 2017; Available from: https:\/\/medica-musc.researchcommons.org\/theses\/329"},{"key":"2131_CR99","doi-asserted-by":"publisher","unstructured":"Wei J, Cui F, Huang Z, Li Z, Mao Z, Zhang P. Acid sensing to inflammaging: mechanisms and therapeutic promise of GPR68 (OGR1) in aging-related diseases. Front Aging [Internet]. 2025 [cited 2026 Jan 9];6. Available from: https:\/\/www.frontiersin.org\/journals\/aging\/articles\/https:\/\/doi.org\/10.3389\/fragi.2025.1684450\/full","DOI":"10.3389\/fragi.2025.1684450\/full"},{"key":"2131_CR100","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1152\/jn.00285.2024","volume":"132","author":"B Bizup","year":"2024","unstructured":"Bizup B, Tzounopoulos T. On the genesis and unique functions of zinc neuromodulation. J Neurophysiol. 2024;132:1241\u201354. https:\/\/doi.org\/10.1152\/jn.00285.2024.","journal-title":"J Neurophysiol"},{"key":"2131_CR101","doi-asserted-by":"crossref","unstructured":"Riddy DM, Kammoun HL, Murphy AJ, Bosnyak-Gladovic S, Gonzalez RD, la Merlin F. J, Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms. BMJ Open Diab Res Care [Internet]. 2021 [cited 2026 Jan 9];9. Available from: https:\/\/drc.bmj.com\/content\/9\/2\/e002285","DOI":"10.1136\/bmjdrc-2021-002285"},{"key":"2131_CR102","unstructured":"Kapellos T. Critical assessment of the role of cannabinoid receptor 2 in inflammation [Internet] [http:\/\/purl.org\/dc\/dcmitype\/Text]. University of Oxford; 2016 [cited 2026 Jan 9]. Available from: https:\/\/ora.ox.ac.uk\/objects\/uuid:23d8a031-ac0c-4c07-b670-8cabfeb1a251."},{"key":"2131_CR103","doi-asserted-by":"crossref","unstructured":"\u0218erban M, Toader C, Covache-Busuioc R-A, \u0218erban M, Toader C, Covache-Busuioc R-A. The Endocannabinoid System in Human Disease: Molecular Signaling, Receptor Pharmacology, and Therapeutic Innovation. International Journal of Molecular Sciences [Internet]. 2025 [cited 2026 Jan 9];26. Available from: https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11132","DOI":"10.3390\/ijms262211132"},{"key":"2131_CR104","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/imr.12752","volume":"289","author":"T L\u00e4mmermann","year":"2019","unstructured":"L\u00e4mmermann T, Kastenm\u00fcller W. Concepts of GPCR-controlled navigation in the immune system. Immunol Rev. 2019;289:205\u201331. https:\/\/doi.org\/10.1111\/imr.12752.","journal-title":"Immunol Rev"},{"key":"2131_CR105","unstructured":"Lenham RK. Development of novel therapeutic agents designed to enhance insulin secretion through activation of the trace amine-associated receptor 1 (TAAR1) [Internet] [doctoral]. Nottingham Trent University; 2024 [cited 2026 Jan 9]. Available from: https:\/\/irep.ntu.ac.uk\/id\/eprint\/53836\/"},{"key":"2131_CR106","doi-asserted-by":"crossref","unstructured":"Vaganova AN, Shemyakova TS, Lenskaia KV, Rodionov RN, Steenblock C, Gainetdinov RR et al. Trace Amine-Associated Receptors and Monoamine-Mediated Regulation of Insulin Secretion in Pancreatic Islets. Biomolecules [Internet]. 2023 [cited 2026 Jan 9];13. Available from: https:\/\/www.mdpi.com\/2218-273X\/13\/11\/1618","DOI":"10.3390\/biom13111618"},{"key":"2131_CR107","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.immuni.2016.09.019","volume":"45","author":"CJ Gro\u00df","year":"2016","unstructured":"Gro\u00df CJ, Gro\u00df O. PKA has the gall to oppose NLRP3. Immunity. 2016;45:707\u20139. https:\/\/doi.org\/10.1016\/j.immuni.2016.09.019.","journal-title":"Immunity"},{"key":"2131_CR108","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41375-019-0436-6","volume":"33","author":"MZ Ratajczak","year":"2019","unstructured":"Ratajczak MZ, Adamiak M, Thapa A, Bujko K, Brzezniakiewicz-Janus K, Lenkiewicz AM. NLRP3 inflammasome couples purinergic signaling with activation of the complement cascade for the optimal release of cells from bone marrow. Leukemia. 2019;33:815\u201325. https:\/\/doi.org\/10.1038\/s41375-019-0436-6.","journal-title":"Leukemia"},{"key":"2131_CR109","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14408","volume":"30","author":"H Du","year":"2023","unstructured":"Du H, Li C, Gao R, Tan Y, Wang B, Peng Y, et al. Inhibition of the interaction between microglial adenosine 2A receptor and NLRP3 inflammasome attenuates neuroinflammation posttraumatic brain injury. CNS Neurosci Ther. 2023;30:e14408. https:\/\/doi.org\/10.1111\/cns.14408.","journal-title":"CNS Neurosci Ther"},{"key":"2131_CR110","doi-asserted-by":"publisher","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","volume":"302","author":"K Miura","year":"2012","unstructured":"Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol [Internet]. 2012;302:G1310-1321. https:\/\/doi.org\/10.1152\/ajpgi.00365.2011.","journal-title":"Am J Physiol Gastrointest Liver Physiol [Internet]"},{"key":"2131_CR111","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/13543784.2020.1718106","volume":"29","author":"S Lefere","year":"2020","unstructured":"Lefere S, Devisscher L, Tacke F. Targeting CCR2\/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges. Expert Opin Investig Drugs. 2020;29:89\u201392. https:\/\/doi.org\/10.1080\/13543784.2020.1718106.","journal-title":"Expert Opin Investig Drugs"},{"key":"2131_CR112","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jcmgh.2020.08.012","volume":"11","author":"M Bartneck","year":"2021","unstructured":"Bartneck M, Koppe C, Fech V, Warzecha KT, Kohlhepp M, Huss S, et al. Roles of CCR2 and CCR5 for hepatic macrophage polarization in mice with liver parenchymal cell-specific NEMO deletion. Cell Mol Gastroenterol Hepatol. 2021;11:327\u201347. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.08.012.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2131_CR113","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4330\/wjc.v16.i12.689","volume":"16","author":"W Wang","year":"2024","unstructured":"Wang W, Wang X-M, Zhang H-L, Zhao R, Wang Y, Zhang H-L, et al. Molecular and metabolic landscape of adenosine triphosphate-induced cell death in cardiovascular disease. World J Cardiol [Internet]. 2024;16:689\u2013706. https:\/\/doi.org\/10.4330\/wjc.v16.i12.689.","journal-title":"World J Cardiol [Internet]"},{"key":"2131_CR114","doi-asserted-by":"crossref","unstructured":"Klaver D, Thurnher M, Klaver D, Thurnher M. Control of Macrophage Inflammation by P2Y Purinergic Receptors. Cells [Internet]. 2021 [cited 2026 Jan 9];10. Available from: https:\/\/www.mdpi.com\/2073-4409\/10\/5\/1098.","DOI":"10.3390\/cells10051098"},{"key":"2131_CR115","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/bph.16256","volume":"181","author":"WAE Parker","year":"2024","unstructured":"Parker WAE, Storey RF. The role of platelet P2Y12 receptors in inflammation. Br J Pharmacol. 2024;181:515\u201331. https:\/\/doi.org\/10.1111\/bph.16256.","journal-title":"Br J Pharmacol"},{"key":"2131_CR116","unstructured":"Gaviano L, Fusco I, Coppi E, Dettori I, Lana D, Ugolini F et al. The selective block of adenosine A2Breceptors prevents neuronal death in CA1 hippocampus after oxygen glucose deprivation. 2017 [cited 2026 Jan 9]; Available from: https:\/\/flore.unifi.it\/handle\/2158\/1107841"},{"key":"2131_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172715","volume":"864","author":"X Yu","year":"2019","unstructured":"Yu X, Hao M, Liu Y, Ma X, Lin W, Xu Q, et al. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy. Eur J Pharmacol. 2019;864:172715. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172715.","journal-title":"Eur J Pharmacol"},{"key":"2131_CR118","doi-asserted-by":"publisher","first-page":"S398","DOI":"10.14309\/00000434-201610001-00920","volume":"111","author":"Z Miao","year":"2016","unstructured":"Miao Z, Newland D, Ertl L, Parker R, McMahon J, Zhang P, et al. Reduction of liver fibrosis by CCR2 antagonist CCX872 in murine models of NASH: 920. Am J Gastroenterol. 2016;111:S398.","journal-title":"Am J Gastroenterol"},{"key":"2131_CR119","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s12350-018-1218-7","volume":"25","author":"E Andrikopoulou","year":"2018","unstructured":"Andrikopoulou E, Hage FG. Adverse effects associated with regadenoson myocardial perfusion imaging. J Nucl Cardiol. 2018;25:1724\u201331. https:\/\/doi.org\/10.1007\/s12350-018-1218-7.","journal-title":"J Nucl Cardiol"},{"key":"2131_CR120","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.healun.2020.02.003","volume":"39","author":"CL Lau","year":"2020","unstructured":"Lau CL, Beller JP, Boys JA, Zhao Y, Phillips J, Cosner M, et al. Adenosine A2A receptor agonist (regadenoson) in human lung transplantation. J Heart Lung Transplant. 2020;39:563\u201370. https:\/\/doi.org\/10.1016\/j.healun.2020.02.003.","journal-title":"J Heart Lung Transplant"},{"key":"2131_CR121","doi-asserted-by":"crossref","unstructured":"D\u0105browska AM, Dudka J, D\u0105browska AM, Dudka J. Mirabegron, a Selective \u03b23-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug. Journal of Clinical Medicine [Internet]. 2023 [cited 2026 Jan 9];12. Available from: https:\/\/www.mdpi.com\/2077-0383\/12\/21\/6897.","DOI":"10.3390\/jcm12216897"},{"key":"2131_CR122","unstructured":"Bel JS. Adipose tissue remodeling in response to corticosterone and \u03b23-adrenergic receptor agonist mirabegron. 2022 [cited 2026 Jan 9]; Available from: https:\/\/knowledgecommons.lakeheadu.ca\/handle\/2453\/4961"},{"key":"2131_CR123","unstructured":"Gong YQ, Liu H, Su ZC, Ba MC, Li XM, Li LJ et al. The Renin-Angiotensin-Aldosterone System: Mechanisms, Pathophysiological Impacts, and Emerging Therapeutic Strategies. Renin-Angiotensin-Aldosterone System - Latest Trends [Internet]. IntechOpen; 2024 [cited 2026 Jan 9]. Available from: https:\/\/www.intechopen.com\/chapters\/1200325"},{"key":"2131_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/nep3.45","author":"S Huang","year":"2024","unstructured":"Huang S, Zhang M. The role of angiotensin II type 1 receptor pathway in cerebral ischemia-reperfusion injury: implications for the neuroprotective effect of ARBs. Neuroprotection. 2024. https:\/\/doi.org\/10.1002\/nep3.45.","journal-title":"Neuroprotection"},{"key":"2131_CR125","volume-title":"Inflammation in chronic and acute heart failure","author":"L Baumhove","year":"2025","unstructured":"Baumhove L. Inflammation in chronic and acute heart failure. [Groningen]: University of Groningen; 2025."},{"key":"2131_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111410","volume":"124","author":"KD Singh","year":"2024","unstructured":"Singh KD, Karnik SS. Implications of \u03b2-arrestin biased signaling by angiotensin II type 1 receptor for cardiovascular drug discovery and therapeutics. Cell Signal. 2024;124:111410. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111410.","journal-title":"Cell Signal"},{"key":"2131_CR127","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/HYPERTENSIONAHA.123.19419","volume":"81","author":"NM Mathieu","year":"2024","unstructured":"Mathieu NM, Nakagawa P, Grobe JL, Sigmund CD. Insights into the role of angiotensin-II AT1 receptor-dependent \u03b2-arrestin signaling in cardiovascular disease. Hypertension. 2024;81:6\u201316. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.19419.","journal-title":"Hypertension"},{"key":"2131_CR128","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","volume":"27","author":"B Pang","year":"2024","unstructured":"Pang B, Dong G, Pang T, Sun X, Liu X, Nie Y, et al. Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction. Angiogenesis. 2024;27:623\u201339. https:\/\/doi.org\/10.1007\/s10456-024-09938-4.","journal-title":"Angiogenesis"},{"key":"2131_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1422686","volume":"15","author":"B Pang","year":"2024","unstructured":"Pang B, Dong G, Pang T, Sun X, Liu X, Nie Y, et al. Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality. Front Pharmacol. 2024;15:1422686. https:\/\/doi.org\/10.3389\/fphar.2024.1422686.","journal-title":"Front Pharmacol"},{"key":"2131_CR130","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.7150\/ijbs.95853","volume":"20","author":"J Wang","year":"2024","unstructured":"Wang J, Zhuang H, Jia L, He X, Zheng S, Ji K, et al. Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia\/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy. Int J Biol Sci. 2024;20:4458\u201375. https:\/\/doi.org\/10.7150\/ijbs.95853.","journal-title":"Int J Biol Sci"},{"key":"2131_CR131","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jare.2024.10.030","volume":"75","author":"J Wang","year":"2025","unstructured":"Wang J, Pu X, Zhuang H, Guo Z, Wang M, Yang H, et al. Astragaloside IV alleviates septic myocardial injury through DUSP1-Prohibitin 2 mediated mitochondrial quality control and ER-autophagy. J Adv Res. 2025;75:561\u201380. https:\/\/doi.org\/10.1016\/j.jare.2024.10.030.","journal-title":"J Adv Res"},{"key":"2131_CR132","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1875-5364(25)60838-7","volume":"23","author":"X Chang","year":"2025","unstructured":"Chang X, Zhou S, Huang Y, Liu J, Wang Y, Guan X, et al. Zishen huoxue decoction (ZSHX) alleviates ischemic myocardial injury (MI) via Sirt5-\u03b2-tubulin mediated synergistic mechanism of \u201cmitophagy-unfolded protein response\u201d and mitophagy. Chin J Nat Med. 2025;23:311\u201321. https:\/\/doi.org\/10.1016\/S1875-5364(25)60838-7.","journal-title":"Chin J Nat Med"},{"key":"2131_CR133","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1096\/fj.201600256","volume":"31","author":"K Parzych","year":"2017","unstructured":"Parzych K, Zetterqvist AV, Wright WR, Kirkby NS, Mitchell JA, Paul-Clark MJ. Differential role of pannexin-1\/ATP\/P2X7 axis in IL-1\u03b2 release by human monocytes. FASEB J. 2017;31:2439\u201345. https:\/\/doi.org\/10.1096\/fj.201600256.","journal-title":"FASEB J"},{"key":"2131_CR134","unstructured":"Xue J. Changes in Calcium Cycling and Its Mechanisms in Sinoatrial-node underlying the TAC-induced Heart Failure in Mouse [Internet] [Theses]. Universit\u00e9 Paris-Saclay; 2020 [cited 2026 Jan 9]. Available from: https:\/\/theses.hal.science\/tel-03148869"},{"key":"2131_CR135","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cellsig.2017.01.024","volume":"41","author":"S Rajagopal","year":"2018","unstructured":"Rajagopal S, Shenoy SK. GPCR desensitization: acute and prolonged phases. Cell Signal. 2018;41:9\u201316. https:\/\/doi.org\/10.1016\/j.cellsig.2017.01.024.","journal-title":"Cell Signal"},{"key":"2131_CR136","doi-asserted-by":"crossref","unstructured":"Wu F, Bu S, Wang H, Wu F, Bu S, Wang H. Role of TRP Channels in Metabolism-Related Diseases. International Journal of Molecular Sciences [Internet]. 2024 [cited 2026 Jan 9];25. Available from: https:\/\/www.mdpi.com\/1422-0067\/25\/2\/692","DOI":"10.3390\/ijms25020692"},{"key":"2131_CR137","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i4.98995","volume":"16","author":"J-X Zhu","year":"2025","unstructured":"Zhu J-X, Pan Z-N, Li D. Intracellular calcium channels: potential targets for type 2 diabetes mellitus? World J Diabetes. 2025;16:98995. https:\/\/doi.org\/10.4239\/wjd.v16.i4.98995.","journal-title":"World J Diabetes"},{"key":"2131_CR138","doi-asserted-by":"publisher","DOI":"10.34133\/research.0159","volume":"6","author":"C Zhong","year":"2023","unstructured":"Zhong C, Yang J, Zhang Y, Fan X, Fan Y, Hua N, et al. TRPM2 mediates hepatic ischemia\u2013reperfusion injury via Ca2+-induced mitochondrial lipid peroxidation through increasing ALOX12 expression. Research. 2023;6:0159. https:\/\/doi.org\/10.34133\/research.0159.","journal-title":"Research"},{"key":"2131_CR139","doi-asserted-by":"crossref","unstructured":"Deng Q, Zhu Y, Zhang M, Fei A, Liang J, Zheng J et al. Ferroptosis as a potential new therapeutic target for diabetes and its complications. 2023 [cited 2026 Jan 9]; Available from: https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/12\/3\/EC-22-0419.xml","DOI":"10.1530\/EC-22-0419"},{"key":"2131_CR140","doi-asserted-by":"publisher","unstructured":"Eser A, Colombel J-F, Rutgeerts P, Vermeire S, Vogelsang H, Braddock M et al. Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn\u2019s Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study. Inflamm Bowel Dis [Internet]. 2015;21:2247\u201353. Available from: https:\/\/doi.org\/10.1097\/MIB.0000000000000514","DOI":"10.1097\/MIB.0000000000000514"},{"key":"2131_CR141","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/17425255.2020.1711884","volume":"16","author":"M Miao","year":"2020","unstructured":"Miao M, De Clercq E, Li G. Clinical significance of chemokine receptor antagonists. Expert Opinion on Drug Metabolism & Toxicology. 2020;16:11\u201330. https:\/\/doi.org\/10.1080\/17425255.2020.1711884.","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"2131_CR142","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/cts.12397","volume":"9","author":"E Lefebvre","year":"2016","unstructured":"Lefebvre E, Gottwald M, Lasseter K, Chang W, Willett M, Smith P, et al. Pharmacokinetics, safety, and CCR2\/CCR5 antagonist activity of cenicriviroc in participants with mild or moderate hepatic impairment. Clin Transl Sci. 2016;9:139\u201348. https:\/\/doi.org\/10.1111\/cts.12397.","journal-title":"Clin Transl Sci"},{"key":"2131_CR143","doi-asserted-by":"crossref","unstructured":"Procopio MC, Lauro R, Nasso C, Carerj S, Squadrito F, Bitto A et al. Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways. Biomedicines [Internet]. 2021 [cited 2026 Jan 9];9. Available from: https:\/\/www.mdpi.com\/2227-9059\/9\/2\/204","DOI":"10.3390\/biomedicines9020204"},{"key":"2131_CR144","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00210-015-1206-2","volume":"389","author":"N Puri","year":"2016","unstructured":"Puri N, Mohey V, Singh M, Kaur T, Pathak D, Buttar HS, et al. Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats. Naunyn Schmiedebergs Arch Pharmacol. 2016;389:361\u20138. https:\/\/doi.org\/10.1007\/s00210-015-1206-2.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2131_CR145","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00228-023-03614-0","volume":"80","author":"L Ma","year":"2024","unstructured":"Ma L, Xiong L, Huang G. Effects of mirabegron on brown adipose tissue and metabolism in humans: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2024;80:317\u201333. https:\/\/doi.org\/10.1007\/s00228-023-03614-0.","journal-title":"Eur J Clin Pharmacol"},{"key":"2131_CR146","doi-asserted-by":"crossref","unstructured":"Vela JM. Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy? Front Pharmacol [Internet]. 2020 [cited 2026 Jan 9];11. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2020.582310\/full.","DOI":"10.3389\/fphar.2020.582310"},{"key":"2131_CR147","doi-asserted-by":"publisher","unstructured":"Jansen TL, Kl\u00fcck V, Janssen M, Comarniceanu A, Efd\u00e9 M, Scribner CL et al. P160 The first phase 2A proof-of-concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile\u2122 (OLT1177\u2122), in acute gout. Annals of the Rheumatic Diseases [Internet]. 2019;78:A70\u20131. Available from: https:\/\/doi.org\/10.1136\/annrheumdis-2018-EWRR2019.142","DOI":"10.1136\/annrheumdis-2018-EWRR2019.142"},{"key":"2131_CR148","doi-asserted-by":"publisher","unstructured":"Kl\u00fcck V, Jansen TLTA, Janssen M, Comarniceanu A, Efd\u00e9 M, Tengesdal IW et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. The Lancet Rheumatology [Internet]. 2020;2:e270\u201380. Available from: https:\/\/doi.org\/10.1016\/S2665-9913(20)30065-5","DOI":"10.1016\/S2665-9913(20)30065-5"},{"key":"2131_CR149","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","volume":"77","author":"GF Wohlford","year":"2021","unstructured":"Wohlford GF, Van Tassell BW, Billingsley HE, Kadariya D, Canada JM, Carbone S, et al. Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II\u2013III systolic heart failure. J Cardiovasc Pharmacol. 2021;77:49. https:\/\/doi.org\/10.1097\/FJC.0000000000000931.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2131_CR150","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.2147\/DDDT.S506957","volume":"19","author":"JS Min","year":"2025","unstructured":"Min JS, Jo SJ, Lee S, Kim DY, Kim DH, Lee CB, et al. A comprehensive review on the pharmacokinetics and drug\u2212drug interactions of approved GLP-1 receptor agonists and a dual GLP-1\/GIP receptor agonist. Drug Des Devel Ther. 2025;19:3509\u201337. https:\/\/doi.org\/10.2147\/DDDT.S506957.","journal-title":"Drug Des Devel Ther"},{"key":"2131_CR151","doi-asserted-by":"publisher","unstructured":"Wang K, Luo H, Liu L, Gao H, Song Y, Li D. Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis. Front Pharmacol [Internet]. 2025 [cited 2026 Jan 9];16. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2025.1577628\/full","DOI":"10.3389\/fphar.2025.1577628\/full"},{"key":"2131_CR152","doi-asserted-by":"crossref","unstructured":"Mai W, Liao Y. Targeting IL-1\u03b2 in the Treatment of Atherosclerosis. Front Immunol [Internet]. 2020 [cited 2026 Jan 9];11. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2020.589654\/full.","DOI":"10.3389\/fimmu.2020.589654"},{"key":"2131_CR153","doi-asserted-by":"crossref","unstructured":"Tsioufis P, Theofilis P, Tsioufis K, Tousoulis D, Tsioufis P, Theofilis P et al. The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches. International Journal of Molecular Sciences [Internet]. 2022 [cited 2026 Jan 9];23. Available from: https:\/\/www.mdpi.com\/1422-0067\/23\/24\/15937","DOI":"10.3390\/ijms232415937"},{"key":"2131_CR154","doi-asserted-by":"publisher","unstructured":"Kayongo A, Nyiro B, Siddharthan T, Kirenga B, Checkley W, Lutaakome Joloba M et al. Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease. Front Cell Infect Microbiol [Internet]. 2023 [cited 2026 Jan 9];13. Available from: https:\/\/www.frontiersin.org\/journals\/cellular-and-infection-microbiology\/articles\/https:\/\/doi.org\/10.3389\/fcimb.2023.1146571\/full","DOI":"10.3389\/fcimb.2023.1146571\/full"},{"key":"2131_CR155","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41569-024-01037-7","volume":"21","author":"SS Adkar","year":"2024","unstructured":"Adkar SS, Leeper NJ. Efferocytosis in atherosclerosis. Nat Rev Cardiol. 2024;21:762\u201379. https:\/\/doi.org\/10.1038\/s41569-024-01037-7.","journal-title":"Nat Rev Cardiol"},{"key":"2131_CR156","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCULATIONAHA.116.025684","volume":"135","author":"Y Kojima","year":"2017","unstructured":"Kojima Y, Weissman IL, Leeper NJ. The role of efferocytosis in atherosclerosis. Circulation. 2017;135:476\u201389. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025684.","journal-title":"Circulation"},{"key":"2131_CR157","doi-asserted-by":"publisher","unstructured":"Abdelnabi MN, Hassan GS, Shoukry NH. Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease. Front Immunol [Internet]. 2024 [cited 2026 Jan 9];15. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2024.1437046\/full","DOI":"10.3389\/fimmu.2024.1437046\/full"},{"key":"2131_CR158","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/cei\/uxae035","volume":"218","author":"J Li","year":"2024","unstructured":"Li J, Wu Z, Wu Y, Hu X, Yang J, Zhu D, et al. IL-22, a vital cytokine in autoimmune diseases. Clin Exp Immunol. 2024;218:242\u201363. https:\/\/doi.org\/10.1093\/cei\/uxae035.","journal-title":"Clin Exp Immunol"},{"key":"2131_CR159","unstructured":"Nhan A. Impact of Omega-3 Fatty Acid Supplementation on Baseline Levels of Inflammatory Markers in the General Population. Honors Undergraduate Theses [Internet]. 2017; Available from: https:\/\/stars.library.ucf.edu\/honorstheses\/246"},{"key":"2131_CR160","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1017\/S0007114515000227","volume":"113","author":"AW Ashor","year":"2015","unstructured":"Ashor AW, Siervo M, Lara J, Oggioni C, Afshar S, Mathers JC. Effect of vitamin C and vitamin E supplementation on endothelial function: a systematic review and meta-analysis of randomised controlled trials. Br J Nutr. 2015;113:1182\u201394. https:\/\/doi.org\/10.1017\/S0007114515000227.","journal-title":"Br J Nutr"},{"key":"2131_CR161","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/JIR.S136742","volume":"11","author":"FH Nielsen","year":"2018","unstructured":"Nielsen FH. Magnesium deficiency and increased inflammation: current perspectives. Journal of Inflammation Research [Internet]. 2018;11:25\u201334. https:\/\/doi.org\/10.2147\/JIR.S136742.","journal-title":"Journal of Inflammation Research [Internet]"},{"key":"2131_CR162","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21608\/eajbsc.2022.213962","volume":"14","author":"NE Kebir","year":"2022","unstructured":"Kebir NE, Zahzeh T. Magnesium deficiency associated with stress, systemic inflammation, and insulin resistance in diabetes mellitus: a review. Egyptian Academic Journal of Biological Sciences C, Physiology and Molecular Biology. 2022;14:31\u201346. https:\/\/doi.org\/10.21608\/eajbsc.2022.213962.","journal-title":"Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology"},{"key":"2131_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2023.100677","volume":"47","author":"H Neudorf","year":"2024","unstructured":"Neudorf H, Little JP. Impact of fasting & ketogenic interventions on the NLRP3 inflammasome: a narrative review. Biomed J. 2024;47:100677. https:\/\/doi.org\/10.1016\/j.bj.2023.100677.","journal-title":"Biomed J"},{"key":"2131_CR164","unstructured":"He Y, Cheng X, Zhou T, Li D, Peng J, Xu Y et al. \u03b2-Hydroxybutyrate as an epigenetic modifier: Underlying mechanisms and implications. Heliyon [Internet]. 2023 [cited 2026 Jan 9];9. Available from: https:\/\/www.cell.com\/heliyon\/abstract\/S2405-8440(23)08306-8"},{"key":"2131_CR165","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.jacc.2018.04.008","volume":"71","author":"DZI Cherney","year":"2018","unstructured":"Cherney DZI, Lytvyn Y, McCullough PA. Cardiovascular risk reduction in patients with chronic kidney disease. J Am Coll Cardiol. 2018;71:2415\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2018.04.008.","journal-title":"J Am Coll Cardiol"},{"key":"2131_CR166","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","volume":"7","author":"EC Svensson","year":"2022","unstructured":"Svensson EC, Madar A, Campbell CD, He Y, Sultan M, Healey ML, et al. TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol. 2022;7:521\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2022.0386.","journal-title":"JAMA Cardiol"},{"key":"2131_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00249-8","volume":"6","author":"Y Li","year":"2025","unstructured":"Li Y, Guo B. GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets. Mol Biomed [Internet]. 2025;6:11. https:\/\/doi.org\/10.1186\/s43556-025-00249-8.","journal-title":"Mol Biomed [Internet]"},{"key":"2131_CR168","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16234","volume":"45","author":"X Zeng","year":"2025","unstructured":"Zeng X, Wu T, Xu Q, Li L, Yuan Y, Zhu M, et al. Inhibition of IRE-1\u03b1 alleviates pyroptosis and metabolic dysfunction-associated steatohepatitis by suppressing gasdermin D. Liver International [Internet]. 2025;45:e16234. https:\/\/doi.org\/10.1111\/liv.16234.","journal-title":"Liver International [Internet]"},{"key":"2131_CR169","doi-asserted-by":"crossref","unstructured":"Baragetti A, Catapano AL, Magni P, Baragetti A, Catapano AL, Magni P. Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease. International Journal of Molecular Sciences [Internet]. 2020 [cited 2026 Jan 9];21. Available from: https:\/\/www.mdpi.com\/1422-0067\/21\/12\/4459","DOI":"10.3390\/ijms21124459"},{"key":"2131_CR170","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/616747","volume":"2015","author":"J Klen","year":"2015","unstructured":"Klen J, Gori\u010dar K, Jane\u017e A, Dol\u017ean V. NLRP3 inflammasome polymorphism and macrovascular complications in type 2 diabetes patients. J Diabetes Res. 2015;2015:616747. https:\/\/doi.org\/10.1155\/2015\/616747.","journal-title":"J Diabetes Res"},{"key":"2131_CR171","doi-asserted-by":"publisher","unstructured":"Kumarasinghe HS, Gunathilaka TL. Overview of G-protein coupled receptors (GPCRs) in adipose tissues and their regulatory roles in the pathophysiology of human diseases. University of Colombo Review [Internet]. 2023 [cited 2026 Jan 9];4. Available from: https:\/\/ucr.sljol.info\/articles\/https:\/\/doi.org\/10.4038\/ucr.v4i2.164","DOI":"10.4038\/ucr.v4i2.164"},{"key":"2131_CR172","doi-asserted-by":"crossref","unstructured":"Malfacini D, Pfeifer A, Malfacini D, Pfeifer A. GPCR in Adipose Tissue Function\u2014Focus on Lipolysis. Biomedicines [Internet]. 2023 [cited 2026 Jan 9];11. Available from: https:\/\/www.mdpi.com\/2227-9059\/11\/2\/588","DOI":"10.3390\/biomedicines11020588"},{"key":"2131_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102524","volume":"49","author":"FR Alsereidi","year":"2024","unstructured":"Alsereidi FR, Khashim Z, Marzook H, Gupta A, Al-Rawi AM, Ramadan MM, et al. Targeting inflammatory signaling pathways with SGLT2 inhibitors: insights into cardiovascular health and cardiac cell improvement. Curr Probl Cardiol. 2024;49:102524. https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102524.","journal-title":"Curr Probl Cardiol"},{"key":"2131_CR174","doi-asserted-by":"crossref","unstructured":"Bucarey JL, Trujillo-Gonz\u00e1lez I, Paules EM, Espinosa A, Bucarey JL, Trujillo-Gonz\u00e1lez I et al. Myokines and Their Potential Protective Role Against Oxidative Stress in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Antioxidants [Internet]. 2024 [cited 2026 Jan 9];13. Available from: https:\/\/www.mdpi.com\/2076-3921\/13\/11\/1363.","DOI":"10.3390\/antiox13111363"},{"key":"2131_CR175","doi-asserted-by":"crossref","unstructured":"Dobre M-Z, Virgolici B, Dunca-Stefan DCA, Doicin I-C, Stanescu-Spinu I-I, Dobre M-Z et al. Inflammation\u2014Insulin Resistance Crosstalk and the Central Role of Myokines. International Journal of Molecular Sciences [Internet]. 2025 [cited 2026 Jan 9];27. Available from: https:\/\/www.mdpi.com\/1422-0067\/27\/1\/60","DOI":"10.3390\/ijms27010060"},{"key":"2131_CR176","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00031.2024","volume":"105","author":"J Zheng","year":"2025","unstructured":"Zheng J, Conrad M. Ferroptosis: when metabolism meets cell death. Physiol Rev. 2025;105:651\u2013706. https:\/\/doi.org\/10.1152\/physrev.00031.2024.","journal-title":"Physiol Rev"},{"key":"2131_CR177","doi-asserted-by":"publisher","first-page":"C1444","DOI":"10.1152\/ajpcell.00246.2022","volume":"323","author":"A Nisa","year":"2022","unstructured":"Nisa A, Kipper FC, Panigrahy D, Tiwari S, Kupz A, Subbian S. Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection. Am J Physiol Cell Physiol. 2022;323:C1444-74. https:\/\/doi.org\/10.1152\/ajpcell.00246.2022.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2131_CR178","doi-asserted-by":"crossref","unstructured":"Robertson H, Dinkova-Kostova AT, Hayes JD, Robertson H, Dinkova-Kostova AT, Hayes JD. NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis. Cancers [Internet]. 2020 [cited 2026 Jan 9];12. Available from: https:\/\/www.mdpi.com\/2072-6694\/12\/12\/3609","DOI":"10.3390\/cancers12123609"},{"key":"2131_CR179","doi-asserted-by":"publisher","unstructured":"Wang L, Fang X, Ling B, Wang F, Xia Y, Zhang W et al. Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases. Front Cell Neurosci [Internet]. 2024 [cited 2026 Jan 9];18. Available from: https:\/\/www.frontiersin.org\/journals\/cellular-neuroscience\/articles\/https:\/\/doi.org\/10.3389\/fncel.2024.1359453\/full","DOI":"10.3389\/fncel.2024.1359453\/full"},{"key":"2131_CR180","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/ars.2020.8134","volume":"34","author":"G Plascencia-Villa","year":"2021","unstructured":"Plascencia-Villa G, Perry G. Preventive and therapeutic strategies in Alzheimer\u2019s disease: focus on oxidative stress, redox metals, and ferroptosis. Antioxidants & Redox Signaling. 2021;34:591\u2013610. https:\/\/doi.org\/10.1089\/ars.2020.8134.","journal-title":"Antioxidants & Redox Signaling"},{"key":"2131_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/nu16081201","author":"D Wendlocha","year":"2024","unstructured":"Wendlocha D, Kubina R, Krzykawski K, Mielczarek-Palacz A. Selected flavonols targeting cell death pathways in cancer therapy: the latest achievements in research on apoptosis, autophagy, necroptosis, pyroptosis, ferroptosis, and cuproptosis. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16081201.","journal-title":"Nutrients"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02131-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02131-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02131-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:34:07Z","timestamp":1775648047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02131-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":181,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2131"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02131-1","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}